Drug Buyers Defend Class Cert. In 3rd Circ. Generics Case
By P.J. D'Annunzio · November 14, 2025, 6:21 PM EST
Direct purchasers and end-payers in the sprawling multidistrict litigation over alleged price-fixing of generic drugs are fighting requests from Actavis and Mylan to undo class certification in the cases, arguing to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login